Venture Catalysts exits hygiene startup Pee Safe with 9.6x return after OrbiMed-led $32 million round

Venture Catalysts exits hygiene startup Pee Safe with 9.6x return after OrbiMed-led $32 million round



Early stage investment fund Venture Catalysts has fully exited women’s hygiene and wellness brand Pee Safe, generating a 9.6x return on its investment. The exit followed a $32 million funding round led by healthcare-focused private equity firm OrbiMed in January.

Other investors, including We Founder Circle, Alkemi Growth Capital and Alpha Capital, have also exited the company, Venture Catalysts founder Apoorva Ranjan Sharma told ET. Zerodha-backed Rainmatter and Natco Pharma continue to be part of the company’s investor base.

The early-stage investment platform had first backed Pee Safe in August 2017 at a pre-money valuation of Rs 15 crore, investing about Rs 1.6 crore. The exit was at a valuation of around Rs 275 crore.

Sharma said the exit, completed in February 2026 through the secondary component of the round, delivered an internal rate of return (XIRR) of 30.53% for its investors.

The OrbiMed-led round takes Pee Safe’s total funding to about $45.55 million.

“We had already been invested for around 7-8 years and the company had reached a stage where it no longer needed the kind of early support we provided. At this point it requires investors who can bring larger capital and help scale it towards the next phase, potentially an IPO,” said Sharma.